197 related articles for article (PubMed ID: 28469723)
1. Pulmonary actinomycosis mimicking lung cancer on positron emission tomography.
Choi H; Lee H; Jeong SH; Um SW; Kown OJ; Kim H
Ann Thorac Med; 2017; 12(2):121-124. PubMed ID: 28469723
[TBL] [Abstract][Full Text] [Related]
2. Clinical and radiological characteristics of pulmonary actinomycosis mimicking lung malignancy.
Baykal H; Ulger AF; Çelik D; Tanrikulu FB; Tatci E
Rev Assoc Med Bras (1992); 2022 Mar; 68(3):372-376. PubMed ID: 35442366
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and treatment outcomes of pulmonary actinomycosis.
Hoca NT; Berktaş MB; Söyler Y; Celep C; Tanrıkulu FB
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):8064-8072. PubMed ID: 36394726
[TBL] [Abstract][Full Text] [Related]
4. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
5. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
6. Dual time point fluorodeoxyglucose positron emission tomography/computed tomography in differentiation between malignant and benign lesions in cancer patients. Does it always work?
Saleh Farghaly HR; Mohamed Sayed MH; Nasr HA; Abdelaziz Maklad AM
Indian J Nucl Med; 2015; 30(4):314-9. PubMed ID: 26430314
[TBL] [Abstract][Full Text] [Related]
7. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
8. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
[TBL] [Abstract][Full Text] [Related]
10. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
Tsushima Y; Tateishi U; Uno H; Takeuchi M; Terauchi T; Goya T; Kim EE
Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359
[TBL] [Abstract][Full Text] [Related]
12. Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.
Cho WI; Chang UK
J Neurosurg Spine; 2011 Feb; 14(2):177-83. PubMed ID: 21214309
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary actinomycosis mimicking lung cancer on
Miyazaki S; Fujito T; Kondo Y; Kuno Y; Mori S; Yamashita R; Ishida J; Nara Y; Ikeda T
J Med Case Rep; 2022 Jul; 16(1):255. PubMed ID: 35773705
[TBL] [Abstract][Full Text] [Related]
14. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.
Hickeson M; Yun M; Matthies A; Zhuang H; Adam LE; Lacorte L; Alavi A
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1639-47. PubMed ID: 12458399
[TBL] [Abstract][Full Text] [Related]
15. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
16. Multimodality FDG PET/CT appearance of pulmonary tuberculoma mimicking lung cancer and pathologic correlation in a tuberculosis-endemic country.
Zheng Z; Pan Y; Guo F; Wei H; Wu S; Pan T; Li J
South Med J; 2011 Jun; 104(6):440-5. PubMed ID: 21886034
[TBL] [Abstract][Full Text] [Related]
17. The role of 11C-choline positron emission tomography-computed tomography and videomediastinoscopy in the evaluation of diseases of middle mediastinum.
Liu Q; Peng ZM; Liu QW; Yao SZ; Zhang L; Meng L; Chen JH
Chin Med J (Engl); 2006 Apr; 119(8):634-9. PubMed ID: 16635407
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary actinomycosis which was clinically suggested lung cancer; report of a case].
Kogure S; Yamamoto N; Watanabe F; Yuasa U; Tokui T; Shomura S
Kyobu Geka; 2011 Mar; 64(3):254-7. PubMed ID: 21404566
[TBL] [Abstract][Full Text] [Related]
19. Role of ¹⁸F-FDG PET/CT in differentiation of a benign lesion and metastasis on the ribs of cancer patients.
Choi HS; Yoo IeR; Park HL; Choi EK; Kim SH; Lee WH
Clin Imaging; 2014; 38(2):109-14. PubMed ID: 24361174
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
